These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 1973058)

  • 1. [Effects of phenothiazine and dibenzazepine derivatives on the muscarinic cholinergic system].
    Brusova EG
    Biull Eksp Biol Med; 1992 Jan; 113(1):60-2. PubMed ID: 1391868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor binding potencies of chlorpromazine, trifluoperazine, fluphenazine and their 10-N-substituted analogues.
    Savelyeva MV; Baldenkov GN; Kaverina NV
    Biomed Biochim Acta; 1988; 47(12):1085-7. PubMed ID: 2855395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the relative hydrophobicity and interaction with striatal dopamine receptors in the bull of representative dialkylaminoalkyl and dialkylaminoacyl phenothiazine derivatives].
    Brusova EG; Savel'eva MV
    Biull Eksp Biol Med; 1988 Aug; 106(8):163-5. PubMed ID: 2901277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moracizine and ethacizine effects on membrane receptors.
    Ratner EI; Baldenkov GN; Grigorian GY; Rosenshtraukh LV; Tkachuk VA
    Arzneimittelforschung; 1989 Jul; 39(7):766-9. PubMed ID: 2675852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The interaction of dialkylaminoacyl derivatives of phenothiazine, dibenzazepine and dibenzdiazepine with opiate receptors].
    Brusova EG; Likhosherstov AM; Gritsenko AN
    Eksp Klin Farmakol; 1996; 59(2):20-3. PubMed ID: 8974557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differences in the efficiency of their interaction with membrane receptors of the dialkylaminoalkyl and dialkylaminoacyl derivatives of phenothiazine].
    Savel'eva MV; Ratner EI; Baldenko GN; Kaverina NV
    Biull Eksp Biol Med; 1990 Mar; 109(3):266-8. PubMed ID: 1973058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical pharmacology of neuroleptics: focus on new generation compounds.
    Richelson E
    J Clin Psychiatry; 1996; 57 Suppl 11():4-11. PubMed ID: 8941166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical structure of phenothiazines and their biological activity.
    Jaszczyszyn A; Gąsiorowski K; Świątek P; Malinka W; Cieślik-Boczula K; Petrus J; Czarnik-Matusewicz B
    Pharmacol Rep; 2012; 64(1):16-23. PubMed ID: 22580516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible Biological and Clinical Applications of Phenothiazines.
    Varga B; Csonka Á; Csonka A; Molnár J; Amaral L; Spengler G
    Anticancer Res; 2017 Nov; 37(11):5983-5993. PubMed ID: 29061777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies.
    Kumar A; Vigato C; Boschi D; Lolli ML; Kumar D
    Eur J Med Chem; 2023 Jun; 254():115337. PubMed ID: 37060756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-receptor interactions.
    Suvarna BS
    Kathmandu Univ Med J (KUMJ); 2011; 9(35):203-7. PubMed ID: 22609508
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.